BioSpace News Archive

Beleave Inc. is pleased to announce that it has received binding commitments for total proceeds of $5,000,000 at a price of $1.75 per unit.

Henry Schein, Inc. announced today that the Company will present at four investor conferences in May:

BlinkBio Inc. announced that the USPTO issued patent no. US 9,931,407 covering BlinkBio’s SiLinker and Payload Cassette technologies, primary components of the Company’s Tunable Drug Conjugate (TDC) Platform.

ArunA Biomedical announced it will present data at the 2018 International Society for Extracellular Vesicles (ISEV) Annual Meeting occurring May 2-6 in Barcelona, Spain.

Entasis Therapeutics Holdings Inc. announced an exclusive license agreement for ETX2514 in the Asia-Pacific region and a global strategic development collaboration.

Joint funding agreement is between the Governments of Canada and British Columbia to help the company build a state-of-the-art advanced manufacturing facility

Syntimmune, Inc. is a clinical-stage biotechnology company developing antibody therapeutics targeting FcRn

The Istituto Oncologico Veneto (IOV) has acquired MILabs’ latest generation VECTor5CT as a key imaging tool to support its translational oncology mission, entrusted by the Italian Ministry of Health and the Organization of the European Cancer Institutes.

Eli Lilly and Company and China’s National Center for Cardiovascular Diseases (NCCD) announced plans to collaborate across four strategic initiatives to advance the scientific understanding of type 2 diabetes and related complications, such as cardiovascular disease (CVD), and improve care for people living with the condition.

DYSIS Medical Ltd announces that the National Institute for Health and Care Excellence (NICE) has updated its original 2012 guidance on adjunctive colposcopy technologies.